JP2024516713A5 - - Google Patents
Info
- Publication number
- JP2024516713A5 JP2024516713A5 JP2023568216A JP2023568216A JP2024516713A5 JP 2024516713 A5 JP2024516713 A5 JP 2024516713A5 JP 2023568216 A JP2023568216 A JP 2023568216A JP 2023568216 A JP2023568216 A JP 2023568216A JP 2024516713 A5 JP2024516713 A5 JP 2024516713A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- cdr
- seq
- chain complementarity
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163185896P | 2021-05-07 | 2021-05-07 | |
| US63/185,896 | 2021-05-07 | ||
| US202163283147P | 2021-11-24 | 2021-11-24 | |
| US63/283,147 | 2021-11-24 | ||
| PCT/US2022/028202 WO2022236142A2 (en) | 2021-05-07 | 2022-05-06 | Chimeric receptors and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024516713A JP2024516713A (ja) | 2024-04-16 |
| JP2024516713A5 true JP2024516713A5 (enExample) | 2025-05-14 |
Family
ID=83933024
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023568216A Pending JP2024516713A (ja) | 2021-05-07 | 2022-05-06 | キメラ受容体およびその使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240173410A1 (enExample) |
| EP (1) | EP4334346A4 (enExample) |
| JP (1) | JP2024516713A (enExample) |
| KR (1) | KR20240004680A (enExample) |
| AU (1) | AU2022270717A1 (enExample) |
| CA (1) | CA3217614A1 (enExample) |
| IL (1) | IL308148A (enExample) |
| TW (1) | TW202309091A (enExample) |
| WO (1) | WO2022236142A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3873540A4 (en) | 2018-10-31 | 2022-07-27 | Mayo Foundation for Medical Education and Research | METHODS AND MATERIALS FOR THE TREATMENT OF CANCER |
| CA3116412A1 (en) | 2018-10-31 | 2020-05-07 | Humanigen, Inc. | Materials and methods for treating cancer |
| WO2020092839A1 (en) | 2018-10-31 | 2020-05-07 | Mayo Foundation For Medical Education And Research | Methods and materials for treating cancer |
| AU2024256204C1 (en) * | 2023-04-17 | 2025-12-18 | Senti Biosciences, Inc. | Antigen-binding domains and methods of use thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2875980A1 (en) * | 2012-06-06 | 2013-12-12 | Oncomed Pharmaceuticals, Inc. | Binding agents that modulate the hippo pathway and uses thereof |
| WO2019024979A1 (en) * | 2017-07-31 | 2019-02-07 | Institute For Research In Biomedicine | FUNCTIONAL DOMAIN ANTIBODIES IN THE ELBOW REGION |
| WO2020191344A1 (en) * | 2019-03-20 | 2020-09-24 | The Regents Of The University Of California | Claudin-6 bispecific antibodies |
| WO2020223445A1 (en) * | 2019-04-30 | 2020-11-05 | Senti Biosciences, Inc. | Chimeric receptors and methods of use thereof |
| CN111378037B (zh) * | 2020-06-01 | 2020-09-01 | 南京诺艾新生物技术有限公司 | 一种抗hIL-33人源化单抗及其应用 |
-
2022
- 2022-05-06 JP JP2023568216A patent/JP2024516713A/ja active Pending
- 2022-05-06 TW TW111117214A patent/TW202309091A/zh unknown
- 2022-05-06 CA CA3217614A patent/CA3217614A1/en active Pending
- 2022-05-06 WO PCT/US2022/028202 patent/WO2022236142A2/en not_active Ceased
- 2022-05-06 IL IL308148A patent/IL308148A/en unknown
- 2022-05-06 EP EP22799728.5A patent/EP4334346A4/en active Pending
- 2022-05-06 AU AU2022270717A patent/AU2022270717A1/en active Pending
- 2022-05-06 KR KR1020237040933A patent/KR20240004680A/ko active Pending
-
2023
- 2023-11-07 US US18/504,037 patent/US20240173410A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102777002B1 (ko) | 항글리피칸-3 항체 및 이의 응용 | |
| EP3738609B1 (en) | Antigen binding molecules comprising a tnf family ligand trimer | |
| CN106519034B (zh) | 抗pd-1抗体及其用途 | |
| JP2018533371A5 (enExample) | ||
| WO2020060406A1 (en) | Novel bispecific antibodies for use in the treatment of hematological malignancies | |
| KR20190034588A (ko) | 키메라 항원 수용체 및 pd-1 억제제의 조합 요법 | |
| IL268206B1 (en) | Bcma-targeting antibody and use thereof | |
| CN111727057A (zh) | 与lag3和pd1结合的治疗分子 | |
| JP2022542559A5 (enExample) | ||
| CN111848809A (zh) | 靶向Claudin18.2的CAR分子、其修饰的免疫细胞及用途 | |
| JP2024504820A (ja) | 抗ｔｎｆｒ２ヒト化抗体及びその使用 | |
| CN116368154A (zh) | 三特异性结合剂 | |
| US20230235064A1 (en) | Bispecific immune cell engagers with binding specificity for hla-g and another antigen | |
| CN113454111A (zh) | 抗体配制剂 | |
| JP2023549555A5 (enExample) | ||
| JP2019537449A5 (enExample) | ||
| JP2023545517A5 (enExample) | ||
| US20240180968A1 (en) | Adgre2 chimeric receptor nk cell compositions and methods of use | |
| IL302148A (en) | Chimeric receptors and methods of use thereof | |
| CN118696062A (zh) | 人源化抗cd28抗体及其与抗cd40的双特异性抗体 | |
| TW202317640A (zh) | 一種抗人pd-l1人源化抗體或其抗原結合片段及其應用 | |
| JP7725066B2 (ja) | ヒト化抗ｐｄ－ｌ１抗体 | |
| WO2024193669A1 (zh) | 抗tnfr2/抗pd-1或ctla-4双特异性抗体及其应用 | |
| KR20230162597A (ko) | 안정적인 다중 특이성 분자 및 그 이용 | |
| JP2022552786A5 (enExample) |